losartan has been researched along with Hyperactivity, Motor in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, L | 1 |
| Zhu, R | 1 |
| Bu, Q | 1 |
| Li, Y | 1 |
| Shao, X | 1 |
| Gu, H | 1 |
| Kong, J | 1 |
| Luo, L | 1 |
| Long, H | 1 |
| Guo, W | 1 |
| Tian, J | 1 |
| Zhao, Y | 1 |
| Cen, X | 1 |
1 other study available for losartan and Hyperactivity, Motor
| Article | Year |
|---|---|
Brain Renin-Angiotensin System Blockade Attenuates Methamphetamine-Induced Hyperlocomotion and Neurotoxicity.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Lin | 2018 |